TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,745,000 | +23.5% | 99,664 | -26.0% | 0.00% | 0.0% |
| Q1 2021 | $2,222,000 | -57.7% | 134,767 | -52.7% | 0.00% | 0.0% |
| Q4 2020 | $5,252,000 | -47.6% | 284,980 | -61.3% | 0.00% | -66.7% |
| Q3 2020 | $10,025,000 | -11.7% | 736,580 | +16.2% | 0.00% | 0.0% |
| Q2 2020 | $11,355,000 | +708.8% | 633,663 | +350.0% | 0.00% | +200.0% |
| Q1 2020 | $1,404,000 | +22.5% | 140,800 | 0.0% | 0.00% | – |
| Q4 2019 | $1,146,000 | -17.8% | 140,800 | 0.0% | 0.00% | – |
| Q3 2019 | $1,395,000 | +215.6% | 140,800 | +302.3% | 0.00% | – |
| Q2 2019 | $442,000 | +23.8% | 35,000 | 0.0% | 0.00% | – |
| Q1 2019 | $357,000 | +35.7% | 35,000 | 0.0% | 0.00% | – |
| Q4 2018 | $263,000 | -24.9% | 35,000 | 0.0% | 0.00% | – |
| Q3 2018 | $350,000 | -21.0% | 35,000 | 0.0% | 0.00% | – |
| Q2 2018 | $443,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,833,120 | $52,169,000 | 8.78% |
| Copernicus Capital Management, LLC | 227,719 | $3,099,000 | 2.95% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $29,708,000 | 2.67% |
| Baupost Group | 18,044,239 | $242,393,000 | 2.62% |
| Prosight Management, LP | 282,100 | $3,839,000 | 1.83% |
| RTW INVESTMENTS, LP | 3,745,286 | $50,973,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 943,339 | $12,839,000 | 1.16% |
| DAFNA Capital Management LLC | 190,930 | $2,599,000 | 0.84% |
| Endurant Capital Management LP | 176,710 | $2,405,000 | 0.71% |
| Artal Group S.A. | 1,400,000 | $19,054,000 | 0.46% |